TherapeuticsMD (TXMD) Enterprise Value (2009 - 2026)
TherapeuticsMD (TXMD) recorded Enterprise Value of $25.58 million in Q2 2026, up 247.7% from $7.36 million a year earlier and up 9.4% from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) Enterprise Value (2009 - 2026) Analysis & Trends
For FY2025, TherapeuticsMD reported Enterprise Value of $18.87 million, up 288.3% from FY2024.
- Annual Enterprise Value has a five-year compound annual growth rate of -74.7% (FY2020 to FY2025).
- Across earlier years, Enterprise Value came in at $4.86 million in FY2024 (-77.5%), $21.62 million in FY2023 (+472.4%), $3.78 million in FY2022 (-100.0%) and $7.67 billion in FY2021 (-57.5%).
- The Q2 2026 figure is the highest quarterly Enterprise Value since Q2 2023.
- On a year-over-year basis, Enterprise Value has increased for three consecutive quarters, with growth averaging 75.6% over the last eight quarters.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 472.4% in Q4 2023, against a decline of 100.0% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $23.38 million (Q1 2026), $18.87 million (Q4 2025) and $5.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | TherapeuticsMD | 20.14 Mn | -12.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.39 Mn |
| Mar 31, 2026 | 14.96 Mn |
| Dec 31, 2025 | 11.38 Mn |
| Sep 30, 2025 | 5.38 Mn |
| Jun 30, 2025 | 7.36 Mn |
| Mar 31, 2025 | 5.02 Mn |
| Dec 31, 2024 | 4.86 Mn |
| Sep 30, 2024 | 14.10 Mn |
| Jun 30, 2024 | 13.33 Mn |
| Mar 31, 2024 | 22.07 Mn |
| Dec 31, 2023 | 19.17 Mn |
| Sep 30, 2023 | 21.77 Mn |
| Jun 30, 2023 | 29.84 Mn |
| Mar 31, 2023 | 18.56 Mn |
| Dec 31, 2022 | 2.45 Mn |
| Sep 30, 2022 | 23.16 Mn |
| Jun 30, 2022 | 50.60 Mn |
| Mar 31, 2022 | 134.33 Mn |
| Dec 31, 2021 | 7.67 Bn |
| Sep 30, 2021 | 15.62 Bn |
API Access
TherapeuticsMD Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();